These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20858076)

  • 1. Safety, censoring, and intent-to-treat analysis: dangers to generalizability.
    Boulware DR
    Clin Infect Dis; 2010 Oct; 51(8):985-6; author reply 987-9. PubMed ID: 20858076
    [No Abstract]   [Full Text] [Related]  

  • 2. Should antiretroviral therapy be delayed for 10 weeks for patients treated with fluconazole for cryptococcal meningitis?
    Bicanic T; Jarvis JN; Muzoora C; Harrison TS
    Clin Infect Dis; 2010 Oct; 51(8):986-7; author reply 987-9. PubMed ID: 20858077
    [No Abstract]   [Full Text] [Related]  

  • 3. Concerns regarding a randomized study of the timing of antiretroviral therapy in zimbabweans with AIDS and acute cryptococcal meningitis.
    Grant PM; Aberg JA; Zolopa AR
    Clin Infect Dis; 2010 Oct; 51(8):984-5; author reply 987-9. PubMed ID: 20858075
    [No Abstract]   [Full Text] [Related]  

  • 4. Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.
    Makadzange AT; Ndhlovu CE; Takarinda K; Reid M; Kurangwa M; Gona P; Hakim JG
    Clin Infect Dis; 2010 Jun; 50(11):1532-8. PubMed ID: 20415574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Dose Fluconazole Consolidation Therapy for Cryptococcal Meningitis in Sub-Saharan Africa: Much to Gain, Little to Lose.
    Murphy RA; Hatlen TJ; Moosa MS
    AIDS Res Hum Retroviruses; 2018 May; 34(5):399-403. PubMed ID: 29353491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.
    Sungkanuparph S; Filler SG; Chetchotisakd P; Pappas PG; Nolen TL; Manosuthi W; Anekthananon T; Morris MI; Supparatpinyo K; Kopetskie H; Kendrick AS; Johnson PC; Sobel JD; Larsen RA
    Clin Infect Dis; 2009 Sep; 49(6):931-4. PubMed ID: 19681708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study.
    Manosuthi W; Chumpathat N; Chaovavanich A; Sungkanuparph S
    BMC Infect Dis; 2005 Aug; 5():67. PubMed ID: 16120209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raised intracranial pressure complicating cryptococcal meningitis: immune reconstitution inflammatory syndrome or recurrent cryptococcal disease?
    York J; Bodi I; Reeves I; Riordan-Eva P; Easterbrook PJ
    J Infect; 2005 Aug; 51(2):165-71. PubMed ID: 15961162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy.
    King MD; Perlino CA; Cinnamon J; Jernigan JA
    Int J STD AIDS; 2002 Oct; 13(10):724-6. PubMed ID: 12396546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
    Lawrence DS; Youssouf N; Molloy SF; Alanio A; Alufandika M; Boulware DR; Boyer-Chammard T; Chen T; Dromer F; Hlupeni A; Hope W; Hosseinipour MC; Kanyama C; Lortholary O; Loyse A; Meya DB; Mosepele M; Muzoora C; Mwandumba HC; Ndhlovu CE; Niessen L; Schutz C; Stott KE; Wang D; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN
    Trials; 2018 Nov; 19(1):649. PubMed ID: 30470259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral fluconazole 1200 mg/day on QT interval in African adults with HIV-associated cryptococcal meningitis.
    Molloy SF; Bradley J; Karunaharan N; Mputu M; Stone N; Phulusa J; Chawinga C; Gaskell K; Segula D; Ming D; Peirse M; Chanda D; Lakhi S; Loyse A; Kanyama C; Heyderman RS; Harrison TS
    AIDS; 2018 Sep; 32(15):2259-2261. PubMed ID: 30102652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of high-dose fluconazole as salvage therapy for cryptococcal meningitis in patients with AIDS.
    Berry AJ; Rinaldi MG; Graybill JR
    Antimicrob Agents Chemother; 1992 Mar; 36(3):690-2. PubMed ID: 1622188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing central nervous system complications associated with the human immunodeficiency virus.
    Mclauchlan D; Robertson NP
    J Neurol; 2014 Sep; 261(9):1842-5. PubMed ID: 25119844
    [No Abstract]   [Full Text] [Related]  

  • 14. Amphotericin B plus fluconazole for HIV-associated cryptococcal meningitis.
    Harrison TS
    Clin Infect Dis; 2009 Jun; 48(12):1784-6. PubMed ID: 19441979
    [No Abstract]   [Full Text] [Related]  

  • 15. Once-a-day (QD) vs. twice-daily (BID) nevirapine as simplification in PI-treated patients after 2 mos. of BID induction.
    Maserati R; Brandolini M; Cattelan A; Orani A; Sighinolfi L; Andreoni M; Uglietti A; Guaraldi G; Sotgiu G;
    Curr HIV Res; 2011 Apr; 9(3):166-73. PubMed ID: 21443516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of AIDS-associated cryptomeningitis.
    Sachdeva RK; Randev S; Sharma A; Wanchu A; Chakrabarti A; Singh S; Varma S
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1220-6. PubMed ID: 22369456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
    Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
    J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver failure in a child receiving highly active antiretroviral therapy and voriconazole.
    Scherpbier HJ; Hilhorst MI; Kuijpers TW
    Clin Infect Dis; 2003 Sep; 37(6):828-30. PubMed ID: 12955645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Funding and Innovation in Diseases of Neglected Populations: The Paradox of Cryptococcal Meningitis.
    Rodrigues ML
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004429. PubMed ID: 26964103
    [No Abstract]   [Full Text] [Related]  

  • 20. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature.
    Skiest DJ; Hester LJ; Hardy RD
    J Infect; 2005 Dec; 51(5):e289-97. PubMed ID: 16321643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.